Susan J. Curry, PhD

home / authors / susan-j-curry-phd

Articles

Site Logo
March 1st 2004

Cost-Effectiveness of Different Combinations of Bupropion SR Dose and Behavioral Treatment for Smoking Cessation: A Societal Perspective

Harold S. Javitz, PhD Gary E. Swan, PhD Susan M. Zbikowski, PhD Susan J. Curry, PhD Timothy A. McAfee, MD, MPH Donna L. Decker, BA Richard Patterson, MS Lisa M. Jack, MA

Site Logo
October 1st 2002

Women's Reports of Smoking Cessation Advice During Reproductive Health Visits and Subsequent Smoking Cessation

Kathryn I. Pollak, PhD Colleen M. McBride, PhD Delia Scholes, PhD Louis C. Grothaus, MA Diane Civic, PhD Susan J. Curry, PhD

Site Logo
July 1st 2001

Promoting Smoking Abstinence in Pregnant and Postpartum Patients: A Comparison of Two Approaches

Harry A. Lando, PhD Barbara G. Valanis, DPH Edward Lichtenstein, PhD Susan J. Curry, PhD Colleen M. McBride, PhD Phyllis L. Pirie, PhD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
ICYMI: Highlights From IMS 2024
Published: December 17th 2024 | Updated: December 22nd 2024
ICYMI: Highlights From IMS 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo